Company / Current Assets per Share
BioRestorative Therapies, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.45
FY2025
5-year range
$0.45 / $30.00
FY2021-FY2025
Trend
-80.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 4 consecutive years, from $30.00 in FY2021 to $0.45 in FY2025.
Based on SEC 10-K filings.
0.45 in FY2025 with a 5-year CAGR of +61.8%.
Declined from $3.10 to $0.45 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -52.8%
- 5-Year CAGR
- +61.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- BioRestorative Therapies, Inc.'s current assets per share has declined for 4 consecutive years.
- In FY2025, current assets per share decreased 80.9% year-over-year.
- Peak current assets per share was recorded in FY2021.
- Lowest current assets per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.45 | -80.9% |
| FY2024 | $2.37 | -23.6% |
| FY2023 | $3.10 | -27.9% |
| FY2022 | $4.30 | -85.7% |
| FY2021 | $30.00 | +73188.7% |
| FY2020 | $0.04 | +597.2% |
| FY2019 | $0.01 | -80.2% |
| FY2018 | $0.03 | -73.2% |
| FY2017 | $0.11 | +493.7% |
| FY2016 | $0.02 | -89.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026